Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guideline update: adjuvant therapy for triple negative breast cancer in 2022

被引：2

作者：

Ding, Hua ^{[1
]}

Zhang, Li ^{[1
]}

Wang, Yue ^{[1
]}

Liu, Shu ^{[1
]}

机构：

[1] Guizhou Med Univ, Dept Breast Surg, Affiliated Hosp, Guiyang 550001, Peoples R China

来源：

TRANSLATIONAL BREAST CANCER RESEARCH | 2022年 / 3卷

关键词：

CHEMOTHERAPY; DOXORUBICIN; EXPRESSION; MUTATIONS; SURVIVAL; TRIAL; BRCA2;

D O I：

10.21037/tbcr-22-13

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 18 条

[1] Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair [J].

Bolderson, Emma ;

Richard, Derek J. ;

Zhou, Bin-Bing S. ;

Khanna, Kum Kum .

CLINICAL CANCER RESEARCH, 2009, 15 (20) :6314-6320

[2] Pembrolizumab for Early Triple-Negative Breast Cancer [J].

Cetin, Bulent ;

Gumusay, Ozge .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (26)

[3] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741 [J].

Citron, ML ;

Berry, DA ;

Cirrincione, C ;

Hudis, C ;

Winer, EP ;

Gradishar, WJ ;

Davidson, NE ;

Martino, S ;

Livingston, R ;

Ingle, JN ;

Perez, EA ;

Carpenter, J ;

Hurd, D ;

Holland, JF ;

Smith, BL ;

Sartor, CI ;

Leung, EH ;

Abrams, J ;

Schilsky, RL ;

Muss, HB ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1431-1439

[4] BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1 [J].

Drost, Rinske ;

Dhillon, Kiranjit K. ;

van der Gulden, Hanneke ;

van der Heijden, Ingrid ;

Brandsma, Inger ;

Cruz, Cristina ;

Chondronasiou, Dafni ;

Castroviejo-Bermejo, Marta ;

Boon, Ute ;

Schut, Eva ;

van der Burg, Eline ;

Wientjens, Ellen ;

Pieterse, Mark ;

Klijn, Christiaan ;

Klarenbeek, Sjoerd ;

Loayza-Puch, Fabricio ;

Elkon, Ran ;

van Deemter, Liesbeth ;

Rottenberg, Sven ;

van de Ven, Marieke ;

Dekkers, Dick H. W. ;

Demmers, Jeroen A. A. ;

van Gent, Dik C. ;

Agami, Reuven ;

Balmana, Judith ;

Serra, Violeta ;

Taniguchi, Toshiyasu ;

Bouwman, Peter ;

Jonkers, Jos .

JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (08) :2903-2918

[5] Breast cancer in China [J].

Fan, Lei ;

Strasser-Weippl, Kathrin ;

Li, Jun-Jie ;

St Louis, Jessica ;

Finkelstein, Dianne M. ;

Yu, Ke-Da ;

Chen, Wan-Qing ;

Shao, Zhi-Ming ;

Goss, Paul E. .

LANCET ONCOLOGY, 2014, 15 (07) :E279-E289

[6] Triple-Negative Breast Cancer [J].

Foulkes, William D. ;

Smith, Ian E. ;

Reis-Filho, Jorge S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) :1938-1948

[7] Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer [J].

Henderson, IC ;

Berry, DA ;

Demetri, GD ;

Cirrincione, CT ;

Goldstein, LJ ;

Martino, S ;

Ingle, JN ;

Cooper, MR ;

Hayes, DF ;

Tkaczuk, KH ;

Fleming, G ;

Holland, JF ;

Duggan, DB ;

Carpenter, JT ;

Frei, E ;

Schilsky, RL ;

Wood, WC ;

Muss, HB ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :976-983

[8] PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition [J].

Ibrahim, Yasir H. ;

Garcia-Garcia, Celina ;

Serra, Violeta ;

He, Lei ;

Torres-Lockhart, Kristine ;

Prat, Aleix ;

Anton, Pilar ;

Cozar, Patricia ;

Guzman, Marta ;

Grueso, Judit ;

Rodriguez, Olga ;

Teresa Calvo, Maria ;

Aura, Claudia ;

Diez, Orland ;

Rubio, Isabel T. ;

Perez, Jose ;

Rodon, Jordi ;

Cortes, Javier ;

Ellisen, Leif W. ;

Scaltriti, Maurizio ;

Baselga, Jose .

CANCER DISCOVERY, 2012, 2 (11) :1036-1047

[9] Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 [J].

Jones, Stephen ;

Holmes, Frankie Ann ;

O'Shaughnessy, Joyce ;

Blum, Joanne L. ;

Vukelja, Svetislava J. ;

McIntyre, Kristi J. ;

Pippen, John E. ;

Bordelon, James H. ;

Kirby, Robert L. ;

Sandbach, John ;

Hyman, William J. ;

Richards, Donald A. ;

Mennel, Robert G. ;

Boehm, Kristi A. ;

Meyer, Wally G. ;

Asmar, Lina ;

Mackey, Daniel ;

Riedel, Stefan ;

Muss, Hyman ;

Savin, Michael A. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1177-1183

[10] Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores [J].

Lecarpentier, Julie ;

Silvestri, Valentina ;

Kuchenbaecker, Karoline B. ;

Barrowdale, Daniel ;

Dennis, Joe ;

McGuffog, Lesley ;

Soucy, Penny ;

Leslie, Goska ;

Rizzolo, Piera ;

Navazio, Anna Sara ;

Valentini, Virginia ;

Zelli, Veronica ;

Lee, Andrew ;

Al Olama, Ali Amin ;

Tyrer, Jonathan P. ;

Southey, Melissa ;

John, Esther M. ;

Conner, Thomas A. ;

Goldgar, David E. ;

Buys, Saundra S. ;

Janavicius, Ramunas ;

Steele, Linda ;

Ding, Yuan Chun ;

Neuhausen, Susan L. ;

Hansen, Thomas V. O. ;

Osorio, Ana ;

Weitzel, Jeffrey N. ;

Toss, Angela ;

Medici, Veronica ;

Cortesi, Laura ;

Zanna, Ines ;

Palli, Domenico ;

Radice, Paolo ;

Manoukian, Siranoush ;

Peissel, Bernard ;

Azzollini, Jacopo ;

Viel, Alessandra ;

Cini, Giulia ;

Damante, Giuseppe ;

Tommasi, Stefania ;

Peterlongo, Paolo ;

Fostira, Florentia ;

Hamann, Ute ;

Evans, D. Gareth ;

Henderson, Alex ;

Brewer, Carole ;

Eccles, Diana ;

Cook, Jackie ;

Ong, Kai-ren ;

Walker, Lisa .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (20) :2240-+

← 1 2 →